Meta-Analysis
Copyright ©The Author(s) 2016.
World J Meta-Anal. Apr 26, 2016; 4(2): 44-54
Published online Apr 26, 2016. doi: 10.13105/wjma.v4.i2.44
Table 4 Recurrent lesion characteristics
Ref.Follow-up time (mean or median ± SD, range) (mo)
Recurrence rate (%)
Piecemeal resection rate of recurrent lesions (%)
Recurrent lesion histology (EMR:ESD cases)
Treatment of recurrent lesion (EMR:ESD cases)
EMRESDEMRESDEMRESDAdenomaNon-inv cancerSm1Invasive cancerAPCEMRSurgery
Tajika et al[22]53.8 ± 44.6 (3-19114.3 ± 13.4 (3-53)15.41.29410013/16:03/16:00:1/10:07/16:08/16:01/16:1/1
Lee et al[23]26 (IQ range 13-41)17 (IQ range 10-23)25.70.89050-:2/2 (serrated)---0:028/29:2/21/29:0
Kobayashi et al[24]38 (2.8-112.5)19.9 (6.4-43.9)21.4092n/a8/12:03/12:001/12:00:011/12:01/12:0
Saito et al[25]26 ± 17 (6-68)20 ± 13 (6-61)14294100-:3/3--2/33:00:030/33:3/33:0
3/33
Kim et al[26]12 (6-12)12 (6-12)11.84.8-0-1/1:000:0---
Tamegai et al[19]19.2 (3-34)12.2 (3-34)6.30100------:02/2:00:0